Hopital Europeen Marseille
Hopital Europeen Marseille
Marseille, France4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer | Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer | Active, not recruiting | Phase 3 | 2026-05-06 | NCT06311721 | |
| Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) | Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) | Active, not recruiting | Phase 3 | 2026-04-01 | NCT06430866 | |
| Pulmonary Fibrosis During Severe COVID-19 Pneumonia | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, adult acute respiratory distress syndrome, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Not stated | 2026-01-26 | NCT04987528 | |
| Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients | OSA | Recruiting | Not stated | 2024-05-21 | NCT05435794 |